Yingquan Xiong
Mitte, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparison of sGC activator and sGC stimulator in 5/6 nephrectomized rats on high-salt-diet.
Journal: Frontiers in pharmacology
Published: August 13, 2024
GSK343 modulates macrophage M2 polarization through the EZH2/MST1/YAP1 signaling axis to mitigate neurological damage induced by hypercalcemia in CKD mice.
Journal: Cellular signalling
Published: October 16, 2023
Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 12, 2022
Impact of Salt Intake and Renin-Angiotensin-Aldosterone System Blockade on Lung Severe Acute Respiratory Syndrome Coronavirus 2 Host Factors.
Journal: Kidney & blood pressure research
Published: February 16, 2022
Vitamin D status and its association with parathyroid hormone in 23,134 outpatients.
Journal: The Journal of steroid biochemistry and molecular biology
Published: January 18, 2022
Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker.
Journal: BMC nephrology
Published: October 22, 2021
Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease.
Journal: Journal of neuroinflammation
Published: October 15, 2021
Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 16, 2021
Neurorescuing effect of Cinacalcet against hypercalcemia-induced nerve injury in chronic kidney disease via TRAF2/cIAP1/KLF2/SERPINA3 signal axis.
Journal: Cell biology and toxicology
Published: June 06, 2021
Osteoprotegerin is an independent risk factor predicting death in stable renal transplant recipients.
Journal: Clinical nephrology
Published: May 27, 2021
Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant.
Journal: American journal of nephrology
Published: February 10, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026